Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Released first as a weight loss medication in tablet form, it differs from Rybelsus, which is targeted only at type 2 diabetes treatment
The data announced in December 2025 was impressive: Weight loss: Participants on the 12mg dose lost an average of 28.7% of their body weight (32.3 kg or 71.2 pounds) over 68 weeks
Continuing on, it is 2.9 fold less potent than human glucagon and 2.5 fold less potent than human GLP-1
KLOW peptide is a pre-formulated research blend consisting of four synthetic peptides combined at fixed mass ratios in a single vial
US$ 26.21
US$ 24.50
US$ 29.03
US$ 29.68
US$ 20.25
US$ 25.95
US$ 25.35
US$ 26.91
